[Association between SORCS1 rs1416406 and therapeutic effect of exenatide].

Zhou, L M; Xu, W; Yan, X M; Li, M X Y; Liang, H; Weng, J P

Zhou, L M; Xu, W; Yan, X M; Li, M X Y; Liang, H; Weng, J P.

Affiliation

Zhou LM; Department of Endocrinology and Metabolism, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.

Zhonghua Yi Xue Za Zhi ; 97(18): 1415-1419, 2017 May 16.

Article in Zh | MEDLINE | ID: mdl-28535629

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/therapeutic use; Peptides/therapeutic use; Receptors, Cell Surface/metabolism; Venoms/therapeutic use; Blood Glucose; China; Exenatide; Glycated Hemoglobin; Humans; Receptors, Cell Surface/drug effects

Key words

Diabetes mellitus, type 2; Exenatide; Polymorphism, single nucleotide; SORCS1 gene

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Venoms / Receptors, Cell Surface / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Yi Xue Za Zhi Year: 2017 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google